The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

As per The Business Research Company’s Head And Neck Cancer Therapeutics Global Market Report 2023, the head and neck cancer therapeutics market is expected to show significant growth in the forecast period.

Key insights from the head and neck cancer therapeutics market forecast include:

1. Market Size

The global head and neck cancer therapeutics market is projected to increase from $1.38 billion in 2022 to $1.55 billion in 2023, with an 11.8% CAGR. It is anticipated to reach $2.32 billion in 2027, with a 10.7% CAGR.

2. Major Driver

The head and neck cancer therapeutics market is poised for growth due to the increasing prevalence of head and neck cancer. Head and neck cancer involves uncontrolled cell growth in the head and neck tissues. For example, Cancer Research UK predicts a 3% rise in head and neck cancer incidence in the UK between 2023 and 2025, with a 12% increase in related deaths during the same period. Consequently, the escalating prevalence of head and neck cancer fuels the head and neck cancer therapeutics market.

View More On The Head And Neck Cancer Therapeutics Market Report 2023 – https://www.thebusinessresearchcompany.com/report/head-and-neck-cancer-therapeutics-global-market-report

3. Key Trend

Novel therapeutics development is a prominent trend in the head and neck cancer therapeutics market. Leading companies in this market are focused on creating innovative therapies for head and neck cancer to maintain their market position. For example, in February 2020, Debiopharm, a Swiss pharmaceutical manufacturer, secured regulatory approval and a breakthrough therapy designation from the US Food and Drug Administration for Debio 1143, a pioneering therapy. Debio 1143 is a first-of-its-kind oral apoptosis proteins (IAP) antagonist, designed for the treatment of previously untreated, unresectable, locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN). It can be used in combination with other treatments and has shown promising Phase II results.

4. Largest Region

North America was the largest region in the head and neck cancer therapeutics market in 2022.

5. Major Players

Major players in the head and neck cancer therapeutics market are Pfizer Inc., F Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi Aventis LLC, Bristol-Myers-Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Incyte Corporation, Ono Pharmaceutical Co. Ltd., Kyowa Kirin Co. Ltd., Hikma Pharmaceuticals PLC, Clinigen Group plc., Ligand Pharmaceuticals, Acceleron Pharma Inc., Taiho Pharmaceutical Co. Ltd., Boston Biomedical Inc., and AB Science SA.

Request A Sample Of The Global Head And Neck Cancer Therapeutics Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=12426&type=smp

Key Head And Neck Cancer Therapeutics Market Segments
The global head and neck cancer therapeutics market is segmented –
1) By Type: Programmed Cell Death (PD) Inhibitors, Microtubule Inhibitors, Epidermal Growth Factor Receptor (EGFR) Inhibitors
2) By Route Of Administration: Injectable, Oral
3) By Distribution Channel: Retail And Specialty Pharmacies, Hospital Pharmacies, Online Pharmacies
4) By Application: Surgery, Radiation Therapy, Chemotherapy, Immunotherapy, Other Applications

The Head And Neck Cancer Therapeutics Global Market Report 2023  provides an in-depth analysis on the head and neck cancer therapeutics market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the head and neck cancer therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
Intratumoral Cancer Therapies Global Market Report 2023
Metastatic Breast Cancer Treatment Global Market Report 2023
Solid Tumor Cancer Treatment Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model